Amed Ventures — Full Portfolio
7 tracked investments · listed companies and verified rows first
Atia Vision develops OmniVu, a modular shape-changing dual-optic intraocular lens (IOL) that uses the eye's natural accommodative mechanism to restore near, intermediate, and distance vision for cataract patients.
HardwareHealthtechMedical DevicesCampbell, US
Co-investorsThe Capital PartnershipDelos Capital
Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.
HardwareHealthtechMedical DevicesCampbell, US
Nitin Salunke(President & CEO)Jean Orth(Executive Officer)Mariam Maghribi(Executive Officer, Director)
BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)
Co-investors415 CapitalThe Capital PartnershipNovo HoldingsUnorthodox Ventures
Verge Medical (formerly Ostial Corporation) develops medical devices for aorto-ostial vascular interventions, including the FLASH Flex aorto-ostial angioplasty system and the RoVo mechanical thrombectomy device, used by physicians for coronary and peripheral vascular cases.
HealthtechMedical Devices
Mike Buck(Chief Executive Officer)Adam Tschida(General Manager & COO)
Co-investorsDelos Capital
Palo Alto, US
Chihyu Chien(Director)Solomon Endlich(Executive Officer, Director, Promoter)Geoffrey Smith(Director)
Board seatYuan Wei Tai· per SEC Form D · $4.2M raise · filed Sep 2021
Proto Lase provides laser micro-manufacturing and processing services—including ablation, laser marking, tube cutting, and wire stripping—for medical device manufacturers working on cardiovascular, drug delivery, neurovascular, and orthopedic applications.
Advanced ManufacturingHardwareMedical DevicesMaple Grove, US
DARLENE KIEFER(Chief Financial Officer of Issuer)BRADY HATCHER(Director and Chief Operating Officer of Issuer)DARYL KIEFER(Director and Chief Executive Officer of Issuer)
Board seatYuan Wei Tai· per SEC Form D · $3.3M raise · filed Dec 2021
BiotechVan Nuys, US
Eric Leuthardt(Director)Leo Petrossian(Executive Officer, Director)
BoardYuanwei Tai(Director)Kevin Reilly(Director)Fred Khosravi(Director)Stavros Vizirgianakis(Director)
Co-investorsAlly Bridge Group
Rejoni is a company focused on uterine health, developing technology to address women's reproductive and gynecological health needs.
BiotechFemTechHealthtechMedical DevicesBedford, US
AMARPREET SAWHNEY(Executive Officer, Director, Promoter)inAmar Sawhney(Founder)NICK SVENCER(Executive Officer, Director, Promoter)FARHAD KHOSRAVI(Executive Officer, Director, Promoter)
BoardTARA BUTLER(Executive Officer, Director, Promoter)
Co-investorsAscension VenturesClavystBioDelos CapitalFemHealth VenturesIyengar Capital PartnersCatalyst Health Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.